Candel Therapeutics, Inc.
CADL
$4.76
$0.224.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 102.65M | 16.56M | 21.45M | 25.71M | 35.41M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.15M | 1.53M | 1.28M | 1.42M | 1.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 103.80M | 18.09M | 22.74M | 27.14M | 36.80M |
|
|
|||||
| Total Current Assets | 103.80M | 18.09M | 22.74M | 27.14M | 36.80M |
| Net Property, Plant & Equipment | 2.73M | 3.09M | 3.40M | 3.71M | 4.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 329.00K | 341.00K | 347.00K | 368.00K | 382.00K |
| Total Assets | 106.87M | 21.52M | 26.49M | 31.22M | 41.20M |
|
|
|||||
| Total Accounts Payable | 237.00K | 296.00K | 433.00K | 472.00K | 422.00K |
| Total Accrued Expenses | 4.72M | 4.57M | 3.22M | 2.77M | 3.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.46M | 10.40M | 10.35M | 10.29M | 9.41M |
| Total Finance Division Other Current Liabilities | 22.11M | -- | -- | -- | 400.00K |
| Total Other Current Liabilities | 22.11M | -- | -- | -- | 400.00K |
| Total Current Liabilities | 37.53M | 15.27M | 14.00M | 13.54M | 14.18M |
|
|
|||||
| Total Current Liabilities | 37.53M | 15.27M | 14.00M | 13.54M | 14.18M |
| Long-Term Debt | 2.60M | 5.07M | 7.52M | 9.96M | 12.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 407.00K | 555.00K | 698.00K | 837.00K | 973.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 15.89M | 14.25M | 909.00K | 916.00K |
| Total Liabilities | 40.54M | 36.77M | 36.46M | 25.24M | 28.46M |
|
|
|||||
| Common Stock & APIC | 258.98M | 163.32M | 157.96M | 151.68M | 150.22M |
| Retained Earnings | -192.21M | -178.13M | -167.49M | -145.25M | -137.03M |
| Treasury Stock & Other | -448.00K | -448.00K | -448.00K | -448.00K | -448.00K |
| Total Common Equity | 66.33M | -15.26M | -9.97M | 5.98M | 12.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 66.33M | -15.26M | -9.97M | 5.98M | 12.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 66.33M | -15.26M | -9.97M | 5.98M | 12.75M |
|
|
|||||